Pure Global

Drug test, reference standard for qualitative antibody IgM against cytomegalovirus (CMV) - Vietnam Registration 2403395ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug test, reference standard for qualitative antibody IgM against cytomegalovirus (CMV) in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2403395ĐKLH/BYT-HTTB and manufactured by Roche Diagnostics GmbH. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2403395ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403395ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug test, reference standard for qualitative antibody IgM against cytomegalovirus (CMV)
VN: Thuốc thử, chất hiệu chuẩn xét nghiệm định tính kháng thể IgM kháng cytomegalovirus (CMV)
Risk Class TTBYT Loại D

Registration Details

2403395ĐKLH/BYT-HTTB

17001587/ĐKLH-BYT-TB-CT

Elecsys CMV IgM

07027133190

Company Information

GERMANY

Technical Details

In vitro immunoassay for the qualitative determination of IgM antibodies against cytomegalovirus in human serum and plasma. The results obtained with the in vitro immunoassay used as a diagnostic tool for the detection of new CMV infections. The electrochemiluminescence immunoassay “ECLIA” (electrochemiluminescence immunoassay “ECLIA”) is used in base immunodiagnostic analyzers.

Dates and Status

Nov 06, 2024